Case series of nebulizing r‐tPA for COVID‐19 induced acute respiratory distress syndrome
Abstract Fibrin deposition in the alveolar spaces during pulmonary involvement of COVID‐19 impairs the O2/CO2 exchange and leads to respiratory symptoms. In this report, Recombinant Tissue Plasminogen Activator (r‐tPA) has been nebulized to 3 critically ill COVID‐19 patients in order to resolve the...
Main Authors: | Shahideh Amini, Zohre Labbani‐Motlagh, Rasoul Aliannejad, Seyed Mohammad Pourabbas, Mohammad Vasei |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-09-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.6283 |
Similar Items
-
1,2,3-Triazole Derivatives as Novel Antifibrinolytic Drugs
by: Oriol Bosch-Sanz, et al.
Published: (2022-11-01) -
An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1
by: Pestell, Richard George, et al.
Published: (2019) -
Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi
by: Claire S. Whyte, et al.
Published: (2021-02-01) -
The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis
by: Filomena Napolitano, et al.
Published: (2021-02-01) -
NF-κB and tPA Signaling in Kidney and Other Diseases
by: Samantha White, et al.
Published: (2020-05-01)